Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02321995 · ClinicalTrials.gov registry record
A Quantitative Optical Sensor to Monitor Vascular Physiology; A Healthy Volunteer Study
A clinical trial of Healthy Volunteer, sponsored by Zenalux Biomedical.
- Completed
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT02321995 is a study of Healthy Volunteer that has completed, run by Zenalux Biomedical. The registered enrollment target is 10 participants, below the 202-participant average among 112 other Healthy Volunteer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02321995, a study of Healthy Volunteer, has completed, sponsored by Zenalux Biomedical.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate the Zenalux IM1, an optical spectroscopy device with a pressure sensor. The pressure sensor is intended to overcome the inconsistencies attributable to variations in use of the device. This study will involve using the device on healthy volunteers. Three tissue parameters will be used to analyze the pressure effects in two ways: within- and across-subject variability. Measurements will be taken under the tongue and on the inside of the cheek. The device is noninvasive and is approved for preclinical use.
Conditions Studied
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-06 |
| Est. Completion | 2016-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02321995
The ClinicalTrials.gov registry entry for NCT02321995 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 202-participant average among 112 other Healthy Volunteer trials with a reported enrollment target (95% lower). The listed sponsor is Zenalux Biomedical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Volunteer appearing as the primary indexed condition, and to 0 interventions.
NCT02321995 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT02321995 about?
NCT02321995 is a clinical study titled "A Quantitative Optical Sensor to Monitor Vascular Physiology; A Healthy Volunteer Study". This study aims to evaluate the Zenalux IM1, an optical spectroscopy device with a pressure sensor. The pressure sensor is intended to overcome the inconsistencies attributable to variations in use of the device. This study will involve using the device on healthy volunteers. Three tissue parameters...
What is the current status of trial NCT02321995?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2016-06. Estimated completion is 2016-10.
What conditions does trial NCT02321995 study?
This clinical trial studies the following conditions: Healthy Volunteer.
Who is sponsoring clinical trial NCT02321995?
This trial is sponsored by Zenalux Biomedical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02321995 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Healthy Volunteer Study
RECRUITING · Phase 1
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Phosphatidylethanol and Other Ethanol Consumption Markers
RECRUITING · NA
-
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors
RECRUITING · Phase 1
-
A First-in-Human Single and Multiple Ascending Dose Study of MT-201
RECRUITING · Phase 1
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.